한글목차

세계의 SNP 지노타이핑 및 분석 시장 규모는 2024년에 18억 7,300만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 16.8%로 성장하여 2031년까지 54억 7,500만 달러에 이를 것으로 예측됩니다.

SNP는 DNA 염기서열의 특정 부위에서 발생하는 단일염기쌍의 변이를 말합니다. 일반적으로 두 가지 변이형(대립유전자)이 존재하며, 그 중 하나는 인구의 1%-5%에서만 발견됩니다. 평균적으로 두 사람의 DNA 염기서열은 300만 군데 이상 차이가 납니다. 경우에 따라서는 이 돌연변이로 인해 특정 질병이나 형질의 발생 또는 발병 위험을 증가시킬 수 있습니다. SNP 유전형 분석 산업은 동적 대립유전자 특이적 하이브리드화, 분자 비콘, SNP 마이크로어레이 등 여러 부문으로 나뉩니다.

SNP 지노타이핑 분야의 세계 주요 기업으로는 Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad 등이 있습니다. 세계 상위 5개 업체의 점유율은 87% 이상입니다. 주요 기업은 주로 유럽과 북미에 기반을 두고 있습니다. 제품별로는 동적 대립유전자 특이적 하이브리드화가 가장 큰 부문으로, 점유율이 48%를 넘어섰습니다. 또한, 용도별로는 의약품 및 약물유전체학이 가장 큰 용도이며, 52% 이상의 점유율을 차지하고 있습니다.

이 보고서는 SNP 유전자형 분석 및 분석 세계 시장에 대해 총 매출액, 주요 기업의 시장 점유율 및 순위를 중심으로 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

SNP 유전자형 분석 및 분석 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 매출액으로 제시되었습니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, SNP 유전형 분석 및 분석에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.

시장 세분화

기업별

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• Roche
• Bio-rad
• LGC
• Sequenom
• Beckman Coulter
• QIAGEN
• Fluidigm

유형별 부문

• Dynamic Allele-Specific Hybridization
• Molecular Beacons
• SNP Microarrays

용도별 부문

• 의약품 및 약물유전체학
• 진단 조사
• 농업 생명공학
• 육종 및 축산

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for SNP Genotyping and Analysis was estimated to be worth US$ 1873 million in 2024 and is forecast to a readjusted size of US$ 5475 million by 2031 with a CAGR of 16.8% during the forecast period 2025-2031.

A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions. In some cases, this variation results in the one minor allele causing or predisposing the individual to have a certain disease or trait. The SNP Genotyping and Analysis industry can be broken down into several segments, Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays, etc.

Global key players of SNP genotyping and analysis include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, etc. Global top five manufacturers hold a share over 87%. The key players are mainly located in Europe and North America. In terms of product, dynamic allele-Specific hybridization is the largest segment, with a share over 48%. And in terms of application, the largest application is pharmaceuticals and pharmacogenomics, with a share over 52%.

This report aims to provide a comprehensive presentation of the global market for SNP Genotyping and Analysis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of SNP Genotyping and Analysis by region & country, by Type, and by Application.

The SNP Genotyping and Analysis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SNP Genotyping and Analysis.

Market Segmentation

By Company

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• Roche
• Bio-rad
• LGC
• Sequenom
• Beckman Coulter
• QIAGEN
• Fluidigm

Segment by Type

• Dynamic Allele-Specific Hybridization
• Molecular Beacons
• SNP Microarrays

Segment by Application

• Pharmaceuticals and Pharmacogenomics
• Diagnostic Research
• Agricultural Biotechnology
• Breeding and Animal Livestock

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of SNP Genotyping and Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of SNP Genotyping and Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of SNP Genotyping and Analysis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 SNP Genotyping and Analysis Product Introduction
• 1.2 Global SNP Genotyping and Analysis Market Size Forecast (2020-2031)
• 1.3 SNP Genotyping and Analysis Market Trends & Drivers
  • 1.3.1 SNP Genotyping and Analysis Industry Trends
  • 1.3.2 SNP Genotyping and Analysis Market Drivers & Opportunity
  • 1.3.3 SNP Genotyping and Analysis Market Challenges
  • 1.3.4 SNP Genotyping and Analysis Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global SNP Genotyping and Analysis Players Revenue Ranking (2024)
• 2.2 Global SNP Genotyping and Analysis Revenue by Company (2020-2025)
• 2.3 Key Companies SNP Genotyping and Analysis Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies SNP Genotyping and Analysis Product Offered
• 2.5 Key Companies Time to Begin Mass Production of SNP Genotyping and Analysis
• 2.6 SNP Genotyping and Analysis Market Competitive Analysis
  • 2.6.1 SNP Genotyping and Analysis Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by SNP Genotyping and Analysis Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SNP Genotyping and Analysis as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Dynamic Allele-Specific Hybridization
  • 3.1.2 Molecular Beacons
  • 3.1.3 SNP Microarrays
• 3.2 Global SNP Genotyping and Analysis Sales Value by Type
  • 3.2.1 Global SNP Genotyping and Analysis Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global SNP Genotyping and Analysis Sales Value, by Type (2020-2031)
  • 3.2.3 Global SNP Genotyping and Analysis Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Pharmaceuticals and Pharmacogenomics
  • 4.1.2 Diagnostic Research
  • 4.1.3 Agricultural Biotechnology
  • 4.1.4 Breeding and Animal Livestock
• 4.2 Global SNP Genotyping and Analysis Sales Value by Application
  • 4.2.1 Global SNP Genotyping and Analysis Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global SNP Genotyping and Analysis Sales Value, by Application (2020-2031)
  • 4.2.3 Global SNP Genotyping and Analysis Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global SNP Genotyping and Analysis Sales Value by Region
  • 5.1.1 Global SNP Genotyping and Analysis Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global SNP Genotyping and Analysis Sales Value by Region (2020-2025)
  • 5.1.3 Global SNP Genotyping and Analysis Sales Value by Region (2026-2031)
  • 5.1.4 Global SNP Genotyping and Analysis Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America SNP Genotyping and Analysis Sales Value, 2020-2031
  • 5.2.2 North America SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe SNP Genotyping and Analysis Sales Value, 2020-2031
  • 5.3.2 Europe SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific SNP Genotyping and Analysis Sales Value, 2020-2031
  • 5.4.2 Asia Pacific SNP Genotyping and Analysis Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America SNP Genotyping and Analysis Sales Value, 2020-2031
  • 5.5.2 South America SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa SNP Genotyping and Analysis Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions SNP Genotyping and Analysis Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions SNP Genotyping and Analysis Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.3.2 United States SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.4.2 Europe SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.5.2 China SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.6.2 Japan SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.7.2 South Korea SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.8.2 Southeast Asia SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.9.2 India SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Thermo Fisher Scientific
  • 7.1.1 Thermo Fisher Scientific Profile
  • 7.1.2 Thermo Fisher Scientific Main Business
  • 7.1.3 Thermo Fisher Scientific SNP Genotyping and Analysis Products, Services and Solutions
  • 7.1.4 Thermo Fisher Scientific SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Thermo Fisher Scientific Recent Developments
• 7.2 Illumina
  • 7.2.1 Illumina Profile
  • 7.2.2 Illumina Main Business
  • 7.2.3 Illumina SNP Genotyping and Analysis Products, Services and Solutions
  • 7.2.4 Illumina SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Illumina Recent Developments
• 7.3 Agilent Technologies
  • 7.3.1 Agilent Technologies Profile
  • 7.3.2 Agilent Technologies Main Business
  • 7.3.3 Agilent Technologies SNP Genotyping and Analysis Products, Services and Solutions
  • 7.3.4 Agilent Technologies SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Agilent Technologies Recent Developments
• 7.4 Roche
  • 7.4.1 Roche Profile
  • 7.4.2 Roche Main Business
  • 7.4.3 Roche SNP Genotyping and Analysis Products, Services and Solutions
  • 7.4.4 Roche SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Roche Recent Developments
• 7.5 Bio-rad
  • 7.5.1 Bio-rad Profile
  • 7.5.2 Bio-rad Main Business
  • 7.5.3 Bio-rad SNP Genotyping and Analysis Products, Services and Solutions
  • 7.5.4 Bio-rad SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Bio-rad Recent Developments
• 7.6 LGC
  • 7.6.1 LGC Profile
  • 7.6.2 LGC Main Business
  • 7.6.3 LGC SNP Genotyping and Analysis Products, Services and Solutions
  • 7.6.4 LGC SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.6.5 LGC Recent Developments
• 7.7 Sequenom
  • 7.7.1 Sequenom Profile
  • 7.7.2 Sequenom Main Business
  • 7.7.3 Sequenom SNP Genotyping and Analysis Products, Services and Solutions
  • 7.7.4 Sequenom SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Sequenom Recent Developments
• 7.8 Beckman Coulter
  • 7.8.1 Beckman Coulter Profile
  • 7.8.2 Beckman Coulter Main Business
  • 7.8.3 Beckman Coulter SNP Genotyping and Analysis Products, Services and Solutions
  • 7.8.4 Beckman Coulter SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Beckman Coulter Recent Developments
• 7.9 QIAGEN
  • 7.9.1 QIAGEN Profile
  • 7.9.2 QIAGEN Main Business
  • 7.9.3 QIAGEN SNP Genotyping and Analysis Products, Services and Solutions
  • 7.9.4 QIAGEN SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.9.5 QIAGEN Recent Developments
• 7.10 Fluidigm
  • 7.10.1 Fluidigm Profile
  • 7.10.2 Fluidigm Main Business
  • 7.10.3 Fluidigm SNP Genotyping and Analysis Products, Services and Solutions
  • 7.10.4 Fluidigm SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Fluidigm Recent Developments

8 Industry Chain Analysis

• 8.1 SNP Genotyping and Analysis Industrial Chain
• 8.2 SNP Genotyping and Analysis Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 SNP Genotyping and Analysis Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 SNP Genotyping and Analysis Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer